A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Author(s) -
Paul G. Richardson,
Bart Barlogie,
James R. Berenson,
Seema Singhal,
Sundar Jagannath,
David J. Irwin,
S. Vincent Rajkumar,
Gordan Srkalović,
Melissa Alsina,
Raymond Alexanian,
David S. Siegel,
Robert Z. Orlowski,
David J. Kuter,
Steven Limentani,
Stephanie J. Lee,
Teru Hideshima,
DixieLee Esseltine,
Michael Kauffman,
Julian Adams,
David P. Schenkein,
Kenneth C. Anderson
Publication year - 2003
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/t5k2-1964
Subject(s) - bortezomib , refractory (planetary science) , multiple myeloma , medicine , phase (matter) , oncology , chemistry , materials science , metallurgy , organic chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom